SCA
SGNT

Secor Capital Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Secor Capital Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,290
Closed -$164K – 837
2015
Q4 		$164K Buy
+10,290
New +$162K 0.05% 486
2015
Q1 		– Sell
-18,834
Closed -$473K – 612
2014
Q4 		$473K Buy
+18,834
New +$553K 0.2% 195
2014
Q2 		– Sell
-12,522
Closed -$293K – 366
2014
Q1 		$293K Buy
+12,522
New +$274K 0.14% 229

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Secor Capital Advisors's SGNT Position: Q1 2016 in Review

Secor Capital Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q1 2016, closing a stake of 10,290 shares — an estimated $164K sold.

Secor Capital Advisors first reported a position in SGNT in Q1 2014 and held it in 3 quarters. The position peaked at $473K in Q4 2014. 136 funds tracked by Wall St. Rank hold SGNT as of Q1 2016.

  • Secor Capital Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Secor Capital Advisors sold 10,290 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2016, an estimated $164K.
  • Secor Capital Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 3 quarters.
  • Secor Capital Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $473K in Q4 2014.
  • 136 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2016.

Based on Secor Capital Advisors's 13F filing for Q1 2016, filed 10 May 2016.